Three-dimensional QSAR analysis and design of new 1,2,4-oxadiazole antibacterials.

Academic Article


  • The oxadiazole antibacterials, a class of newly discovered compounds that are active against Gram-positive bacteria, target bacterial cell-wall biosynthesis by inhibition of a family of essential enzymes, the penicillin-binding proteins. Ligand-based 3D-QSAR analyses by comparative molecular field analysis (CoMFA), comparative molecular shape indices analysis (CoMSIA) and Field-Based 3D-QSAR evaluated a series of 102 members of this class. This series included inactive compounds as well as compounds that were moderately to strongly antibacterial against Staphylococcus aureus. Multiple models were constructed using different types of energy minimization and charge calculations. CoMFA derived contour maps successfully defined favored and disfavored regions of the molecules in terms of steric and electrostatic properties for substitution.
  • Authors

  • Leemans, Erika
  • Mahasenan, Kiran V
  • Kumarasiri, Malika
  • Spink, Edward
  • Ding, Derong
  • O'Daniel, Peter I
  • Boudreau, Marc
  • Lastochkin, Elena
  • Testero, Sebastian A
  • Yamaguchi, Takao
  • Lee, Mijoon
  • Hesek, Dusan
  • Fisher, Jed F
  • Chang, Mayland
  • Mobashery, Shahriar
  • Status

    Publication Date

  • February 1, 2016
  • Keywords

  • 1,2,4-Oxadiazole
  • 3D-QSAR
  • Anti-Bacterial Agents
  • Antibiotic
  • Cell Wall
  • CoMFA
  • Drug Design
  • Gram-Positive Bacteria
  • Microbial Sensitivity Tests
  • Molecular Conformation
  • Oxadiazoles
  • Quantitative Structure-Activity Relationship
  • Digital Object Identifier (doi)

    Start Page

  • 1011
  • End Page

  • 1015
  • Volume

  • 26
  • Issue

  • 3